Presence of telomerase activity in different musculoskeletal tumor histotypes and correlation with aggressiveness

International Journal of Cancer

Volumn 95, Issue 3, 2001, Pages 156-161

  Sangiorgi, L ^a   Gobbi, G A ^a   Lucarelli, E ^a   Sartorio, S Menghi ^a   Mordenti, M ^a   Ghedini, I ^a   Maini, V ^a   Scrimieri, F ^a   Reggiani, M ^a   Bertoja, A Zambon ^a   Benassi, M S ^a   Picci, P ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Pulmonary metastasis; Sarcoma; Telomerase; Telomere

Indexed keywords

TELOMERASE; TUMOR MARKER;

ARTICLE; BIOPSY; BONE CANCER; BONE CYST; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURGERY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG METASTASIS; MAJOR CLINICAL STUDY; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SOFT TISSUE CANCER; TELOMERE;

BONE NEOPLASMS; HUMANS; NEOPLASM INVASIVENESS; SOFT TISSUE NEOPLASMS; TELOMERASE;

EID: 0035918534     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20010520)95:3<156::AID-IJC1027>3.0.CO;2-L     Document Type: Article

References (43)

1. Blackburn EH. The molecular structure of centromeres and telomeres. Annu Rev Biochem 1984;53:163-94.
2. Moyzis RK, Buckingam JM, Cram LS, Dani M, Deaven LL, Jones MD, et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988;85:6622-6.
3. Meyne J, Ratliff RL, Moyzis RK. Conservation of the human telomere sequence (TTAGGG)n among vertebrates. Proc Natl Acad Sci USA 1989;86:7049-53.
4. Zakian VA. Structure and function of telomeres. Annu Rev Genet 1989;23:579-604.
5. Allshire RC, Gisden JR, Cross SH, Cranston G, Rout D, Sugawara N, et al. Telomeric repeat from T. termophila cross hybridises with human telomeres. Nature (Lond) 1988;332:656-9.
6. Brown WRA. Molecular cloning of human telomeres in yeast. Nature (Lond) 1989;338:774-6.
7. Cross SH, Allshire RC, McKay SJ, McGill NI, Cooke HJ. Cloning of human telomeres by complementation in yeast. Nature (Lond) 1989; 338:771-4.
8. De Lange T, Shiue L, Myers RM, Cox DR, Naylor SL, Killery AM, et al. Structure and variability of human chromosome ends. Mol Cell Biol 1990;10:518-27.
9. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-9.
10. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994;91: 2900-4.
11. Saltman D, Morgan R, Cleary ML, de Lange T. Telomeric structure in cells with chromosome end associations. Chromosoma 1993;102: 121-8.
12. Holzmann K, Blin N, Welter C, Zang KD, Seitz G, Henn H. Telomeric associations and loss of telomeric DNA repeats in renal tumours. Genes Chromosomes Cancer 1993;6:178-81.
13. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985;43: 405-13.
14. Greider CW, Blackburn EH. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 1987;51:887-98.
15. Greider CW, Blackburn EH. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeats synthesis. Nature (Lond) 1989;337:331-7.
16. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal cell layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 1996; 93:6476-81.
17. Holt SE, Wriaht WE, Shay JW. Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 1996;16:2932-9.
18. Cong YS, Wen J, Bacchetti, S. The human telomerase catalytic subunit hTERT: organisation of the gene and characterisation of the promoter. Hum Mol Genet 1999;8:137-42.
19. Yashima K, Milchgrub S, Gollahon LS, Maitra A, Saboorian MH, Shay JW, et al. Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma. Clin Cancer Res 1998;4:229-34.
20. Hoos A, Hepp HH, Kaul S, Ahlert T, Bastert G, Wallwiener D. Telomerase activity correlates with tumour aggressiveness and reflects therapy effect in breast cancer. Int J Cancer 1998;79:8-12.
21. Kinoshita H, Ogawa O, Mishina M, Oka H, Okumura K, Yamabe H, et al. Telomerase activity in adrenal cortical tumours and pheochromocytomas with reference to clinicopathologic features. Urol Res 1998;26:29-32.
22. Lee DH, Yang SC, Hong SJ. Chung BH, Kirn IY. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes. Clin Cancer Res 1998;4:535-8.
23. Le S, Zhu JJ, Anthony DC, Greider CW, Black PM. Telomerase activity in human gliomas. Neurosurgery 1998;42:1120-4.
24. Ohta K, Kanamaru T, Morita Y, Hajashi Y, Ito H, Yamamoto M. Telomerase activity in hepatocellular carcinoma as a predictor of postoperative recurrence. J Gastroenterol 1997;32:791-6.
25. Murakami J, Nagai N, Ohama K, Tahara H, Ide T. Telomerase activity in ovarian tumours. Cancer 1997;80:1085-92.
26. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Coffey DS. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 1996;56:218-22.
27. Campanacci M. Bone and soft tissue tumours. New York: Springer-Verlag, 1999.
28. Enzinger FM, Weiss SW. Soft tissue tumours. St. Louis, MO: Mosby, 1998.
29. Smilenov LB, Morgan SE, Sawant SG, Kastan MB, Pandita TK. Influence of ATM function on telomere methabolism. Oncogene 1997;15:2659-65.
30. Xu D, Gruber A, Peterson C, Pisa P. Telomerase activity and expression of telomerase components in acute myelogenous leukemia. Br J Hematol 1998;102:1367-75.
31. Sawant SG, Gregoire V, Dhar S, Umbricht CB, Cvilic S, Sukumar S, et al. Telomerase activity as a measure for monitoring radiocurability of tumor cells. FASEB J 1999;13:1047-54.
32. Soria JC, Gauthier LR, Raymond E, Granotier C, Moral L, Arman JP, et al. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients. Clin Cancer Res 1999;5: 971-5.
33. Wu K, Lund M, Bang K, Thestrup-Pedersen K. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma. Cancer 1999;86:1056-63.
34. Ferlicot S, Paradis V, Dargere D, Monges G, Bedossa P. Detection of telomerase in hepatocellular carcinomas using a PCR ELISA assay: comparison with hTR expression. J Clin Pathol 1999;52:725-9.
35. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
36. Hiraga S, Ohnishi T, Izumoto S, Miyahara E, Kanemura Y, Matsumura H, et al. Telomerase activity and alterations in telomere length in human brain tumours. Cancer Res 1998;58:2117-25.
37. Schwartz HS, Julian SF, Sciadini MF, Miller LK, Butler MG. Telomerase activity in giant cell tumour of bone. Cancer 1995;75:1094-9.
38. Aue G, Muralidhar B, Schwartz HS, Butler MG. Telomerase activity in skeletal sarcomas. Ann Surg Oncol 1998;5:627-34.
39. Kido A, Schneider-Stock R, Hauptmann K, Roessner A. Telomerase activity in benign bone tumours and tumour-like lesions. Pathol Res Pract 1999;195:753-7.
40. Schneider-Stock R, Rys J, Jaeger V, Niezabitowski A, Kruezac A, Sokolowski A, et al. Prognostic significance of telomerase activity in soft tissue sarcomas. Int J Oncol 1999;15:775-80.
41. Faraoni I, Turriziani M, Masci G, De Veccis L, Shay JW, Bonmassar E, et al. Decline of telomerase activity as a measure of tumour cell killing by antineoplastic agents in vitro. Clin Cancer Res 1997;3:579-85.
42. Jaeger V, Schneider-Stock R, Gerresheim F, Epplen JT, Serra M, Lippert H, et al. Mixoid liposarcoma with transition to round cell lesion cell cycle regulator genes and telomerase activity characterizing tumor progression: a case report. Hum Pathol 1999;30:1515-9.
43. Schneider-Stock R, Jaeger V, Rys J, Epplen JT, Roessner A. High telomerase activity and high HTRT mRNA expression differentiate pure myxoid and myxoid/round cell liposarcomas. Int J Cancer 2000; 89:63-8.